NYSE:CLB - Core Laboratories Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$82.48 -4.91 (-5.62 %)
(As of 11/20/2018 04:00 PM ET)
Previous Close$87.39
Today's Range$81.54 - $85.87
52-Week Range$80.22 - $130.34
Volume748,982 shs
Average Volume445,295 shs
Market Capitalization$3.82 billion
P/E Ratio41.24
Dividend Yield2.54%
Beta1.64
Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. This segment offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. It also provides proprietary and joint industry studies. The Production Enhancement segment includes services and products relating to reservoir well completions, perforations, stimulations, and production. This segment offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
SectorOils/Energy
Current SymbolNYSE:CLB
Previous Symbol
CUSIPN/A
Phone31-20-420-3191

Debt

Debt-to-Equity Ratio1.83
Current Ratio2.31
Quick Ratio1.85

Price-To-Earnings

Trailing P/E Ratio41.24
Forward P/E Ratio35.71
P/E Growth2.54

Sales & Book Value

Annual Sales$659.81 million
Price / Sales5.53
Cash Flow$2.4475 per share
Price / Cash33.70
Book Value$3.37 per share
Price / Book24.47

Profitability

EPS (Most Recent Fiscal Year)$2.00
Net Income$83.12 million
Net Margins13.21%
Return on Equity68.00%
Return on Assets17.17%

Miscellaneous

Employees4,600
Outstanding Shares44,220,000
Market Cap$3.82 billion
OptionableOptionable

Core Laboratories (NYSE:CLB) Frequently Asked Questions

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Tuesday, October 9th. Investors of record on Friday, October 19th will be paid a dividend of $0.55 per share on Tuesday, November 20th. This represents a $2.20 dividend on an annualized basis and a yield of 2.67%. The ex-dividend date of this dividend is Thursday, October 18th. View Core Laboratories' Dividend History.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) announced its quarterly earnings results on Wednesday, October, 24th. The oil and gas company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.63 by $0.01. The oil and gas company had revenue of $182.15 million for the quarter, compared to the consensus estimate of $178.11 million. Core Laboratories had a net margin of 13.21% and a return on equity of 68.00%. The business's revenue was up 11.8% on a year-over-year basis. During the same period last year, the firm earned $0.46 earnings per share. View Core Laboratories' Earnings History.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, January 30th 2019. View Earnings Estimates for Core Laboratories.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories updated its fourth quarter earnings guidance on Wednesday, October, 24th. The company provided earnings per share (EPS) guidance of $0.48-0.54 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.59. The company issued revenue guidance of $173-176 million, compared to the consensus revenue estimate of $174.91 million.Core Laboratories also updated its Q4 2018 guidance to $0.48-0.54 EPS.

What price target have analysts set for CLB?

15 Wall Street analysts have issued twelve-month price objectives for Core Laboratories' shares. Their predictions range from $87.00 to $130.00. On average, they expect Core Laboratories' stock price to reach $109.8182 in the next year. This suggests a possible upside of 33.1% from the stock's current price. View Analyst Price Targets for Core Laboratories.

What is the consensus analysts' recommendation for Core Laboratories?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 6 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.

Has Core Laboratories been receiving favorable news coverage?

Media stories about CLB stock have trended somewhat positive on Tuesday, according to InfoTrie Sentiment. The research firm scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Core Laboratories earned a news impact score of 0.8 on InfoTrie's scale. They also gave news articles about the oil and gas company a news buzz of 8.0 out of 10, indicating that recent press coverage is very likely to have an effect on the stock's share price in the immediate future.

Who are some of Core Laboratories' key competitors?

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the folowing people:
  • Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 63)
  • Mr. Monty L. Davis, Chief Operating Officer and Sr. VP (Age 64)
  • Mr. Richard L. Bergmark, Exec. VP (Age 65)
  • Mr. Lawrence V. Bruno, Pres & Supervisory Director (Age 58)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 48)

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a number of of institutional and retail investors. Top institutional investors include WCM Investment Management CA (11.01%), BlackRock Inc. (7.35%), Earnest Partners LLC (4.38%), Massachusetts Financial Services Co. MA (4.29%), Royal London Asset Management Ltd. (3.44%) and Epoch Investment Partners Inc. (3.21%). Company insiders that own Core Laboratories stock include Jan Willem Sodderland, Kevin Daniels, Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories.

Which institutional investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including WCM Investment Management CA, Renaissance Technologies LLC, Jackson Square Partners LLC, Russell Investments Group Ltd., Manning & Napier Group LLC, Envestnet Asset Management Inc., Sei Investments Co. and Schroder Investment Management Group. View Insider Buying and Selling for Core Laboratories.

Which institutional investors are buying Core Laboratories stock?

CLB stock was purchased by a variety of institutional investors in the last quarter, including Royal London Asset Management Ltd., Epoch Investment Partners Inc., Fisher Asset Management LLC, Massachusetts Financial Services Co. MA, Select Equity Group L.P., Neuberger Berman Group LLC, BlackRock Inc. and JPMorgan Chase & Co.. Company insiders that have bought Core Laboratories stock in the last two years include Jan Willem Sodderland, Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $82.48.

How big of a company is Core Laboratories?

Core Laboratories has a market capitalization of $3.82 billion and generates $659.81 million in revenue each year. The oil and gas company earns $83.12 million in net income (profit) each year or $2.00 on an earnings per share basis. Core Laboratories employs 4,600 workers across the globe.

What is Core Laboratories' official website?

The official website for Core Laboratories is http://www.corelab.com.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]


MarketBeat Community Rating for Core Laboratories (NYSE CLB)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  363 (Vote Outperform)
Underperform Votes:  496 (Vote Underperform)
Total Votes:  859
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel